#1 - (Black Lines) Triple Bottom starting back on Nov. 2.
#2 - (Orange Line) Rising Support Trend also from the beginning of November.
#3 - (Red Lines) Short term support and resistance trending upward since mid December.
#4 - (Blue Line) Successful Bear Trap resulting in "double bottom" with open at 0.155
#5 - (Grey Line) 8 Month Falling Wedge meeting Support in coming month.
#6 - High potential for catalysts in coming months.
Possible Catalysts by End of January to assist this breakout:
1.) Update from NASDAQ meeting held this month (as to whether an extension to April will be given).
Possible Catalysts by March:
2.) Update regarding FDA Amendment that was sought after regarding Feb 2017 decision to discontinue trial. This news might take sometime depending on results / urgency.
Possible Catalysts anticipated by April to May:
3.) Preliminary results for ARGS-003 and ARGS-004 trials.
4.) Today 3 CTO requests were submitted - Obviously very speculative but thats a lot of financial information that wants to be withheld.
#2 - (Orange Line) Rising Support Trend also from the beginning of November.
#3 - (Red Lines) Short term support and resistance trending upward since mid December.
#4 - (Blue Line) Successful Bear Trap resulting in "double bottom" with open at 0.155
#5 - (Grey Line) 8 Month Falling Wedge meeting Support in coming month.
#6 - High potential for catalysts in coming months.
Possible Catalysts by End of January to assist this breakout:
1.) Update from NASDAQ meeting held this month (as to whether an extension to April will be given).
Possible Catalysts by March:
2.) Update regarding FDA Amendment that was sought after regarding Feb 2017 decision to discontinue trial. This news might take sometime depending on results / urgency.
Possible Catalysts anticipated by April to May:
3.) Preliminary results for ARGS-003 and ARGS-004 trials.
4.) Today 3 CTO requests were submitted - Obviously very speculative but thats a lot of financial information that wants to be withheld.